After in vitro re-culture, low-dose IL-15 pre-activated NK cells exhibited lower DNAM-1-dependent cytotoxicity against primary AML blasts than IL-12/15/18 pre-activated NK cells (44). The gene discussed is IL15; the disease is acute myeloid leukemia.